← Back to headlines
Dianthus Therapeutics Misses Q4 EPS and Revenue Estimates
Dianthus Therapeutics reported a GAAP EPS of -$1.43, missing estimates by $0.34, and revenue of $0.28M, missing by $0.17M.
9 Mar, 11:30 — 9 Mar, 11:30
Sources
Showing 1 of 1 sources
